News Channels

26 Mar 2020 SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
26 Mar 2020 Ipsen Provides Update on Palovarotene Clinical Programs
26 Mar 2020 Inzomelid completes Phase I studies and shows positive results in the treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
26 Mar 2020 Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset
26 Mar 2020 Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections
26 Mar 2020 U.S. Food and Drug Administration Approves Bristol Myers Squibb’s ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis
26 Mar 2020 Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-Licensing Agreement of 3B Pharmaceutical's Targeted CAIX Radiotherapy
26 Mar 2020 Medicenna's IL-2 Superkine, MDNA19, Demonstrates Best-in-Class Features in a Non-Human Primate Study
26 Mar 2020 Eisai submits marketing authorization application in Japan for anticancer agent denileukin diftitox (genetic recombinant) for cutaneous T-cell lymphoma and peripheral T-cell lymphoma
26 Mar 2020 Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
26 Mar 2020 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
26 Mar 2020 Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend XmAb Antibody Technology in Investigational Antibodies to Treat COVID-19
26 Mar 2020 Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
25 Mar 2020 Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
25 Mar 2020 TEPMETKO® (Tepotinib) Approved in Japan for Advanced NSCLC with METex14 Skipping Alterations
25 Mar 2020 ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer
25 Mar 2020 AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
25 Mar 2020 Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies
25 Mar 2020 Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
24 Mar 2020 Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients with Advanced Urothelial Carcinoma (COAXIN)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top